MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
about
MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerUltrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAsCo-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.Far beyond the usual biomarkers in breast cancer: a review.miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.Tumor surveillance by circulating microRNAs: a hypothesis.Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.Differentially expressed wound healing-related microRNAs in the human diabetic cornea.MicroRNA as tools and therapeutics in lung cancerMultidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric CancerRobust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers.Establishment of Lipofection Protocol for Efficient miR-21 Transfection into Cortical Neurons In Vitro.MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.The microRNA networks of TGFβ signaling in cancer.Drug resistance-related miRNAs in hepatocellular cancer.Prognosis-related microRNAs in esophageal cancer.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.MicroRNA-21 and multiple myeloma: small molecule and big function.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Prognostic markers in esophageal cancer: from basic research to clinical use.Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR.The bounty of nature for changing the cancer landscape.MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.Separation of microRNA 21 as a cancer marker from glioblastoma cell line using molecularly imprinted polymer coated on silica nanoparticles.Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells.MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4.MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition.MicroRNA-210 and its theranostic potential.Emerging role of microRNA-21 in cancer.MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer.Are Circulating microRNAs Involved in Tumor Surveillance?miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN.Noncoding RNA in drug resistant sarcoma.Prognostic evaluation of microRNA-210 in various carcinomas: Evidence from 19 studies.Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group.
P2860
Q26777313-F9CB50AB-F9C7-4A1E-8CB5-1BD4D8478F47Q30367369-DD7D7EAC-A2A7-4853-B5A6-FC83C3CFDB03Q33873637-94B279FB-A216-41D3-98C1-27E4856B828EQ33935217-5C269098-A009-4162-A67D-C1E6D72804B3Q34048535-09CC1C15-74A3-42FE-B396-E7449A77756BQ34324228-D45B07D5-D6E3-44DF-9B1B-C5E9C25D9FE5Q34454908-AB5121C2-D9EE-4033-9245-D51650934B7CQ35078390-724BAABF-1A09-41A9-A352-D26950FB7C3BQ35738706-CBE5F147-AB24-415B-B36B-EAE771C5B010Q35751343-09BE8AD2-CC89-4AC8-B0A7-76221B7BF81DQ35822555-F0AA3745-BDEB-4D1B-9394-B82ED4BDC008Q36382803-B50E7FE5-59AE-4167-B525-CD3EC84F6268Q36557155-CFF9D9A0-2198-4979-AD65-5D47E1D1946EQ37573748-37506889-7EC6-48F4-842D-B0E75CF42AD8Q37687374-EB77FA02-C075-4D87-B163-1A0C2E297F37Q38170025-5EF3EC42-F7B4-486C-957A-2621B264A245Q38185706-0309AA4F-1AE5-4C79-9349-680A4FBB28ECQ38186129-3ABE6182-84AB-4660-BBDE-E7C87E483623Q38202662-BABE2135-1CFA-4EDB-862D-4B1C1E4DBEC1Q38224963-9296BFD0-125C-496B-A229-063E4C953591Q38258284-703D94E9-B83F-40CE-AB69-B2680A7CD98FQ38525673-DBDC6015-2560-43B5-B25F-3B0283BA4F6FQ38637648-CC8BFC8A-3C23-4A37-AAA1-6B7073088CA2Q38660048-F60573E6-CFAB-40BA-B412-5C2E8EB9DD87Q38707912-3875E78D-E550-4528-8DE9-1C286FA5A668Q38737099-5FBC4B80-EDD5-4EAA-B97F-1423AC97CE93Q38757932-9724D736-0A66-471D-906A-CE17C10E59B2Q38768272-E4E1F90D-514D-4635-8476-E27EF62DE098Q38795162-44F6CD86-4E91-4464-A884-2B9F57841E6CQ38828580-E8C8B3BA-74B3-4B39-B1AA-7A12B567C548Q38860322-6EEC796A-1C42-4B56-BF76-9958D52930BEQ38881607-D120191A-0DB9-4921-A519-CB11F32D60D2Q38971467-4FD33652-086A-4F8E-BE21-07EA427D3F74Q38995616-B4D3A008-2A39-4768-91FB-BF4368CBC4CDQ40274014-F700915B-98C5-4F65-9CD9-957B8C790EE8Q41143550-EF36D508-9FE8-4CAA-BFF7-FE073F0CB0BBQ41924654-EE704852-D36A-47A5-A217-D165061E2C9DQ43847258-0FF27D16-5F01-43D1-A949-B414F34BD6B3Q47314965-29D6395B-1A2C-4264-B566-19CBD52DFA64Q48159392-F40C2BA2-0D3B-4F4E-90D9-586C72E37F1D
P2860
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
@en
type
label
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
@en
prefLabel
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
@en
P2093
P2860
P1476
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
@en
P2093
Daiming Fan
Hongwei Zhang
Kaichun Wu
Qingchuan Zhao
Yujie Zhang
P2860
P304
P356
10.1517/14728222.2013.819853
P407
P577
2013-07-19T00:00:00Z